Safety of Tofacitinib in a Real-World Cohort of Patients With Ulcerative Colitis

Title
Safety of Tofacitinib in a Real-World Cohort of Patients With Ulcerative Colitis
Authors
Keywords
IBD, Janus Kinases/Antagonists and Inhibitors, Side Effect
Journal
Publisher
Elsevier BV
Online
2020-07-04
DOI
10.1016/j.cgh.2020.06.050

Ask authors/readers for more resources

Reprint

Contact the author

Find Funding. Review Successful Grants.

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started